MarketCap
Facebook
X
Telegram
Danaher Corporation ROCE Ratio | DHR
Annual ROCE Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.93 | 9.82 | 9.73 | 15.04 | 14.12 | 10.64 | 5.72 | 7.92 | 7.22 | 7.16 | 8.25 | 10.86 | 10.86 | 10.77 | 9.89 | 14.95 | 12.38 | 18.22 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.22 | 5.72 | 10.69 |
Quarterly ROCE Ratio Danaher Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q4 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.51 | 9.12 | 10.01 | 9.96 | 8.92 | 9.3 | 9.42 | 6.96 | 11.24 | 13.27 | 15.75 | 17.98 | 18.44 | 18.83 | 17.12 | 12.43 | 12.43 | 17.12 | 16.81 | 12.12 | 14.86 | 13.97 | 11.04 | 6.61 | 9.79 | 9.62 | 10.18 | 10.8 | 10.68 | 10.76 | 10.77 | 10.83 | 11.32 | 11.56 | 11.44 | 11.35 | 10.96 | 11.11 | 11.63 | 11.96 | 11.54 | 10.53 | 9.9 | 9.13 | 10.08 | 11.76 | 13.05 | 14.32 | 14.43 | 14.22 | 14.07 | 13.94 | 14.66 | 15.13 | 15.8 | 16.64 | 16.71 | 16.54 | 15.89 | 15.48 | 13.8 | 13.99 | 13.34 | 12.8 | 12.88 | 14.21 | 16.46 | 3.01 | 5.32 | 5.2 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.83 | 3.01 | 12.33 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Celcuity
CELC
|
-40.76 | $ 67.13 | -4.11 % | $ 3.14 B |  USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.9 | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
16.41 | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
63.01 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
0.42 | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 30.39 | -1.32 % | $ 28.8 B |  Niderland |
 |
RadNet
RDNT
|
2.13 | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-67.05 | $ 10.05 | 2.55 % | $ 419 M | USA |
 |
Neuronetics
STIM
|
-29.33 | $ 2.01 | -7.8 % | $ 133 M | USA |
 |
T2 Biosystems
TTOO
|
177.14 | - | -39.35 % | $ 313 K | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 719.09 | -0.35 % | $ 271 B | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-25.56 | $ 155.43 | -2.12 % | $ 19.5 B | USA |
 |
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
1.76 | $ 10.63 | -8.68 % | $ 361 M |  Israel |
 |
VolitionRx Limited
VNRX
|
63.48 | $ 0.19 | -6.2 % | $ 23.9 M |  Singapore |
 |
Natera
NTRA
|
-15.84 | $ 311.81 | -1.92 % | $ 42.6 B | USA |
 |
IQVIA Holdings
IQV
|
10.16 | $ 275.46 | -1.21 % | $ 47.4 B | USA |
 |
Agilent Technologies
A
|
21.94 | $ 178.84 | -0.74 % | $ 50.8 B | USA |
 |
Quotient Limited
QTNT
|
72.05 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
-4.75 | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
11.54 | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
376.98 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
-36.9 | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
13.43 | - | - | $ 1.49 B | USA |
 |
DexCom
DXCM
|
21.72 | $ 79.92 | -1.42 % | $ 31.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-8.4 | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
61.76 | $ 696.77 | -1.4 % | $ 56 B | USA |
 |
Illumina
ILMN
|
29.64 | $ 214.84 | -2.69 % | $ 33.3 B | USA |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 3.05 | -3.48 % | $ 99 K | USA |
|
Biodesix
BDSX
|
-39.8 | $ 10.04 | -2.95 % | $ 75.8 M | USA |
 |
BioNano Genomics
BNGO
|
-65.83 | $ 1.25 | 7.66 % | $ 6.81 M | USA |
 |
Bioventus
BVS
|
11.27 | $ 11.18 | 1.5 % | $ 745 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.03 | $ 25.83 | -1.22 % | $ 795 M | USA |
 |
CareDx, Inc
CDNA
|
-9.52 | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | Britain |
 |
Biomerica
BMRA
|
-202.28 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.39 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |